Decreased Expression of SATB2: A Novel Independent Prognostic Marker of Worse Outcome in Laryngeal Carcinoma Patients (original) (raw)
Figure 3
Survival curves for patients with high SATB2 expression versus low SATB2-expressing carcinoma.
The 5-y overall survival rate was 85.3% in the high SATB2 protein expression group (green line) (n = 48), but it was only 54.3% in the low expression group (blue line) (n = 38), P = .002.